Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
Researcher Profiles
Home
>
Our Research
>
Researcher Profiles
Bookmark or Share
Display Options
Display Options
+ Increase
/
- Decrease
font size
High contrast version
Printer-friendly version
Profile
Research Activities
News
Publications
Contact Information
Mitchell Sabloff, MSc, MDCM, FRCPC
613-737-8899 x79670
Msabloff@toh.ca
https://orcid.org/0000-0002-0122-6138
News
People with lived experience of cancer are bringing crucial insights to studies
January 11, 2023 - The early days after Gary Davis’s leukemia diagnosis were all a blur. Now cancer-free, Gary is advising our researchers on how to navigate difficult conversations about study participation with patients like himself
Precision medicine approach for leukemia awarded $1.5M
May 1, 2019 - Acute myeloid leukemia (AML) is one of the deadliest forms of cancer. A team of researchers from The Ottawa Hospital and uOttawa is hoping to revolutionize treatment for AML by developing a “precision medicine” approach.
New drug combination destroys chemo-resistant blood cancer
October 22, 2018 - Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients would most likely ...
Bolstering fat cells offers new hope for treating blood cancer
November 6, 2017 - Drs. Mitchell Sabloff and David Allan contributed to a new study led out of McMaster University that is providing hope for people with acute myeloid leukemia (AML). This kind of cancer grows in the bone marrow and inhibits the production of normal bl